Columbus Circle Investors’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Columbus Circle Investors's AMGN Position: Q2 2017 in Review
Columbus Circle Investors sold out of Amgen (AMGN) in Q2 2017, closing a stake of 7,294 shares — an estimated $1.2M sold.
Columbus Circle Investors first reported a position in AMGN in Q2 2013 and held it in 13 quarters. The position peaked at $37.5M in Q2 2014. 1,595 funds tracked by Wall St. Rank hold AMGN as of Q2 2017.
- Columbus Circle Investors reported no remaining Amgen position as of Q2 2017 after selling out during the quarter.
- Columbus Circle Investors sold 7,294 Amgen shares in Q2 2017, an estimated $1.2M.
- Columbus Circle Investors first reported a position in Amgen in Q2 2013 and held it in 13 quarters.
- Columbus Circle Investors's Amgen position peaked at $37.5M in Q2 2014.
- 1,595 funds tracked by Wall St. Rank held Amgen as of Q2 2017.
Based on Columbus Circle Investors's 13F filing for Q2 2017, filed 4 Aug 2017.